Crizotinib just approved in Japan for ROS1+ NSCLC!

Crizotinib was approved last week for #ROS1-positive non-small cell lung cancer in Japan! I learned this from Dr Koichi Goto, Chief of Thoracic Oncology at the National Cancer Center Hospital East in Japan. I met him while wandering through the metastatic #lungcancer posters at #ASCO17.